scispace - formally typeset
Y

Yu Shyr

Researcher at Vanderbilt University Medical Center

Publications -  582
Citations -  45668

Yu Shyr is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 98, co-authored 542 publications receiving 39527 citations. Previous affiliations of Yu Shyr include Vanderbilt University & Ninewells Hospital.

Papers
More filters
Journal Article

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

TL;DR: There is early and frequent genomic amplification of p63 in the development of squamous carcinoma of the lung and that patients with NSCLC showing amplification and overexpression of p 63 have prolonged survival, suggesting that p63 genomic amplification has an early role in lung tumorigenesis and deserves additional evaluation as a biomarker for lung cancer progression.
Journal ArticleDOI

Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma

TL;DR: Gene expression profiles of HPV+ and HPV− tumors were compared with further exploration of the biological effect of HPV in HNSCC to reveal the unique pathways in HPV+ tumors that may explain the different natural history and biological properties of these tumors.

Reamed intramedullary nailing of the femur : 551 cases

TL;DR: In this paper, the results of the treatment of fractures of the femoral shaft with interlocking femoral nails inserted with closed techniques, and to compare the outcomes of fractures nailed by using a fracture table with those stabilized with the leg draped free on a radiolucent table.
Journal ArticleDOI

Reamed intramedullary nailing of the femur: 551 cases.

TL;DR: In this paper, the results of the treatment of fractures of the femoral shaft with interlocking femoral nails were determined for a femoral femur fracture patient with a multiple surgical team approach.
Journal ArticleDOI

The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

Orit Rozenblatt-Rosen, +373 more
- 16 Apr 2020 - 
TL;DR: The Human Tumor Atlas Network (HTAN), part of the NCI Cancer Moonshot Initiative, will establish a clinical, experimental, computational, and organizational framework to generate informative and accessible three-dimensional atlases of cancer transitions for a diverse set of tumor types.